| Aktie | Ticker | 2025/Q4 | 2025/Q3 | 2025/Q2 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | ||
| 4.389.447.587 $ | +900.936.703 $ | +1.071,2 % | 3.583.282.146 $ | +662.435.535 $ | +10,7 % | 3.118.189.972 $ | +83.847.832 $ | +59,1 % | ||
| BANK OF AMERICA CORP /DE/ | BAC | 3.436.596.998 $ | +702.351.888 $ | +25,7 % | 2.734.245.110 $ | +383.710.648 $ | +16,3 % | 2.350.534.462 $ | -152.299.997 $ | -6,1 % |
| IONIS PHARMACEUTICALS INC | IONS | 134.487.000 $ | -114.641.780 $ | -46,0 % | 249.128.780 $ | +55.863.877 $ | +28,9 % | 193.264.903 $ | +55.562.778 $ | +40,3 % |
| CYTOKINETICS INC | CYTK | 212.032.853 $ | -24.295.147 $ | -10,3 % | 236.328.000 $ | +115.732.000 $ | +96,0 % | 120.596.000 $ | -2.942.152 $ | -2,4 % |
| INSMED Inc | INSM | 176.120.000 $ | +156.685.046 $ | +806,2 % | ||||||
| BIOMARIN PHARMACEUTICAL INC | BMRN | 136.689.000 $ | +135.342.799 $ | +10.053,7 % | 1.346.201 $ | +1.346.201 $ | ||||
| LB PHARMACEUTICALS INC | LBRX | 74.633.417 $ | +21.692.642 $ | +41,0 % | 52.940.775 $ | +52.940.775 $ | ||||
| Immunocore Holdings plc | IMCR | 69.558.076 $ | +4.164.076 $ | +6,4 % | 65.394.000 $ | +8.910.000 $ | +15,8 % | 56.484.000 $ | +14.607.703 $ | +34,9 % |
| MoonLake Immunotherapeutics | MLTX | 60.760.736 $ | +60.760.736 $ | |||||||
| GERON CORP | GERN | 42.914.878 $ | -13.387.357 $ | -23,8 % | 56.302.235 $ | -4.327.765 $ | -7,1 % | 60.630.000 $ | -70.239 $ | -0,1 % |
| EXACT SCIENCES CORP | EXAS | 54.710.000 $ | +54.710.000 $ | |||||||
| COMPASS Pathways plc | CMPS | 50.606.829 $ | +5.571.046 $ | +12,4 % | 45.035.783 $ | +20.308.963 $ | +82,1 % | 24.726.820 $ | -611.773 $ | -2,4 % |
| Centessa Pharmaceuticals plc | CNTA | 50.020.000 $ | +43.450.000 $ | +661,3 % | 6.570.000 $ | +6.570.000 $ | ||||
| SOLENO THERAPEUTICS INC | SLNO | 46.300.000 $ | +46.300.000 $ | |||||||
| ANI PHARMACEUTICALS INC | ANIP | 37.708.375 $ | -3.511.625 $ | -8,5 % | 41.220.000 $ | -4.455.000 $ | -9,8 % | 45.675.000 $ | -1.190.000 $ | -2,5 % |
| Autolus Therapeutics plc | AUTL | 4.186.839 $ | -34.236.056 $ | -89,1 % | 38.422.895 $ | +10.756.198 $ | +38,9 % | |||
| ENANTA PHARMACEUTICALS INC | ENTA | 30.859.793 $ | +30.859.793 $ | |||||||
| GH Research PLC | GHRS | 17.875.000 $ | -6.505.000 $ | -26,7 % | 24.380.000 $ | +2.320.000 $ | +10,5 % | |||
| GENMAB A/S | GMAB | 14.760.459 $ | +14.760.459 $ | |||||||
| BICYCLE THERAPEUTICS PLC | BCYC | 8.362.546 $ | +1.850.580 $ | +28,4 % | ||||||
| Xencor Inc | XNCR | 6.444.919 $ | +2.126.328 $ | +49,2 % | 4.318.591 $ | -1.527.440 $ | -26,1 % | |||
| NOVAVAX INC | NVAX | 6.290.815 $ | -3.440.732 $ | -35,4 % | ||||||
| Monopar Therapeutics | MNPR | 6.230.142 $ | +6.230.142 $ | |||||||
| ACADIA PHARMACEUTICALS INC | ACAD | 2.242.514 $ | +2.242.514 $ | |||||||
| Zura Bio Ltd | ZURA | 1.121.531 $ | -692.409 $ | -38,2 % | 1.813.940 $ | -2.422.140 $ | -57,2 % | |||
| MORGAN STANLEY | MS | 49.490 $ | +49.490 $ | |||||||
| 4.389.447.587 $ | +900.936.703 $ | +1.071,2 % | 3.583.282.146 $ | +662.435.535 $ | +10,7 % | 3.118.189.972 $ | +83.847.832 $ | +59,1 % | ||